Memantin Grindeks

Memantine, the active ingredient in Memantin Grindeks, is a NMDA receptor antagonist presented as an oral formulation for oral use. It is prescribed to treat moderate to severe Alzheimer’s disease in adult patients, helping to reduce excitotoxic neuronal damage and support cognitive function.

GNH USA supplies Memantin Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation, ensuring reliable access to this medication for healthcare providers across the European market and beyond.

Memantine is used in the management of Alzheimer’s disease, a neurodegenerative disorder that impairs memory, thinking and daily activities.

- Alzheimer's disease (moderate to severe): improves cognition, functional abilities, and overall clinical status, helping patients maintain independence longer. - Alzheimer's disease (mild to moderate) as add‑on to cholinesterase inhibitors: may provide additional cognitive benefit and slower functional decline when combined with standard therapy. - Behavioral disturbances in Alzheimer’s disease: may reduce agitation, aggression and psychotic symptoms, supporting better caregiver management.

Memantine may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., rash, angioedema, anaphylaxis) - Hepatic dysfunction (elevated liver enzymes, hepatitis)

When prescribing memantine, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: assess renal function and monitor for accumulation. - Hepatic impairment: use with caution and monitor liver enzymes. - History of seizures: monitor closely for increased seizure risk. - Concomitant NMDA antagonists: avoid combined use due to additive effects. - Pregnancy: safety unknown; weigh potential benefits against risks. - Store at room temperature: keep in original packaging, protect from moisture.

Memantine can interact with other medicines, and interactions are classified by their clinical significance.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neuropsychiatric effects. - Ketamine: combined NMDA blockade can potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: memantine may enhance hypotensive effects. - Diuretics: increased risk of dehydration and electrolyte imbalance. - Anticholinergic agents: may worsen cognitive side effects.